Description
| Product Name | CAT.No | Size |
| Tuberculosis.IgG/IgM | TBC00020 | 20T |
| Tuberculosis.IgG/IgM | TBC00040 | 40T |
Product Description
The Biorex Diagnostics TB IgG/IgM Rapid Test is a fast, reliable immunochromatographic assay designed for the qualitative detection of antibodies against Mycobacterium tuberculosis in whole blood, serum, or plasma. This rapid diagnostic tool provides healthcare professionals with a practical solution for early identification of tuberculosis exposure, supporting timely clinical intervention and improved patient care. The test’s dual antibody detection system distinguishes between IgM antibodies, indicative of recent infection, and IgG antibodies, reflecting past exposure, offering comprehensive insight into the patient’s TB status.
Key Features
- Rapid detection – delivers results within minutes for timely decision-making
- Dual antibody identification – detects both IgG and IgM TB antibodies to assess recent and prior exposure
- Versatile sample types – compatible with whole blood, serum, or plasma for flexible clinical use
- Easy to perform – minimal training required, no complex instrumentation necessary
- High sensitivity and specificity – reliable preliminary screening for TB in diverse patient populations
Benefits
The TB IgG/IgM Rapid Test enables early and accurate recognition of tuberculosis, facilitating prompt treatment and reducing the likelihood of disease progression and complications. Its straightforward workflow, rapid turnaround, and sample versatility make it suitable for use in hospitals, clinics, and point-of-care environments, including remote or resource-limited settings. By providing dependable detection of TB antibodies, the test supports public health initiatives aimed at TB surveillance and control.
Routine use of the Biorex TB IgG/IgM Rapid Test allows healthcare providers to quickly identify individuals with potential exposure, helping to prioritise diagnostic follow-up and therapeutic interventions. The assay’s robust performance and reproducibility ensure confidence in preliminary TB screening, while its ease of use minimizes the need for extensive laboratory infrastructure or specialist training. Integrating this test into clinical workflows enhances patient management, aids in early detection programs, and contributes to overall TB control efforts. With Biorex Diagnostics’ commitment to quality and reliability, the TB IgG/IgM Rapid Test delivers a practical, efficient, and clinically relevant solution for monitoring and managing tuberculosis exposure.
Contact Us for more information.